Vericel Corp Ord Stock Year To Date Return

VCEL Stock

USD 57.42 1.11 1.90%

Vericel Corp Ord fundamentals help investors to digest information that contributes to Vericel Corp's financial success or failures. It also enables traders to predict the movement of Vericel Stock. The fundamental analysis module provides a way to measure Vericel Corp's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Vericel Corp stock.

Short Long Term Debt Total Total Assets

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Vericel Corp Ord Company Year To Date Return Analysis

Vericel Corp's Year to Date Return (YTD) is the total return generated from holding a security from the beginning of the current fiscal year. In other words, YTD Return represents the capital appreciation of your investments from the start of the current fiscal year.

YTD Return

(Mean of Monthly Returns - 1)

X

100%

More About Year To Date Return | All Equity Analysis

Vericel Year To Date Return Driver Correlations

Understanding the fundamental principles of building solid financial models for Vericel Corp is extremely important. It helps to project a fair market value of Vericel Stock properly, considering its historical fundamentals such as Year To Date Return. Since Vericel Corp's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Vericel Corp's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Vericel Corp's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Short Term Investments	Common Stock	Property Plant Equipment	Current Deferred Revenue	Long Term Debt	Net Tangible Assets	Long Term Debt Total	Intangible Assets	Short Long Term Debt	Net Invested Capital	Net Working Capital	Capital Stock	Long Term Investments
Total Assets		0.99	0.54	-0.53	0.94	0.99	0.97	0.99	0.91	0.77	0.95	0.95	0.31	0.81	0.95	-0.17	0.84	0.41	0.93	0.93	0.91	0.9
Total Stockholder Equity	0.99		0.46	-0.6	0.92	0.98	0.92	1.0	0.92	0.81	0.97	0.95	0.37	0.83	0.96	-0.19	0.89	0.41	0.94	0.95	0.89	0.88
Net Debt	0.54	0.46		0.19	0.48	0.52	0.68	0.47	0.53	0.36	0.33	0.54	-0.15	0.4	0.47	-0.12	0.31	0.12	0.5	0.46	0.53	0.54
Retained Earnings	-0.53	-0.6	0.19		-0.48	-0.6	-0.36	-0.58	-0.54	-0.51	-0.76	-0.54	-0.58	-0.62	-0.57	-0.11	-0.62	-0.51	-0.54	-0.56	-0.4	-0.45
Accounts Payable	0.94	0.92	0.48	-0.48		0.94	0.93	0.92	0.81	0.63	0.89	0.82	0.07	0.67	0.82	-0.13	0.69	0.37	0.84	0.83	0.91	0.79
Net Receivables	0.99	0.98	0.52	-0.6	0.94		0.94	0.98	0.91	0.76	0.97	0.92	0.33	0.84	0.93	-0.09	0.83	0.49	0.91	0.91	0.89	0.86
Total Liab	0.97	0.92	0.68	-0.36	0.93	0.94		0.93	0.83	0.63	0.85	0.91	0.17	0.73	0.87	-0.11	0.7	0.37	0.88	0.86	0.92	0.89
Total Current Assets	0.99	1.0	0.47	-0.58	0.92	0.98	0.93		0.93	0.83	0.96	0.94	0.37	0.86	0.96	-0.15	0.88	0.45	0.94	0.95	0.88	0.87
Short Term Debt	0.91	0.92	0.53	-0.54	0.81	0.91	0.83	0.93		0.89	0.9	0.83	0.37	0.86	0.91	-0.22	0.9	0.44	0.86	0.88	0.75	0.72
Short Term Investments	0.77	0.81	0.36	-0.51	0.63	0.76	0.63	0.83	0.89		0.78	0.75	0.42	0.83	0.85	-0.25	0.91	0.36	0.8	0.85	0.61	0.62
Common Stock	0.95	0.97	0.33	-0.76	0.89	0.97	0.85	0.96	0.9	0.78		0.9	0.46	0.87	0.92	-0.05	0.87	0.49	0.88	0.89	0.81	0.81
Property Plant Equipment	0.95	0.95	0.54	-0.54	0.82	0.92	0.91	0.94	0.83	0.75	0.9		0.44	0.8	0.94	-0.2	0.85	0.37	0.92	0.91	0.84	0.94
Current Deferred Revenue	0.31	0.37	-0.15	-0.58	0.07	0.33	0.17	0.37	0.37	0.42	0.46	0.44		0.57	0.38	0.08	0.59	0.38	0.3	0.34	0.06	0.39
Long Term Debt	0.81	0.83	0.4	-0.62	0.67	0.84	0.73	0.86	0.86	0.83	0.87	0.8	0.57		0.86	0.21	0.83	0.44	0.79	0.82	0.64	0.7
Net Tangible Assets	0.95	0.96	0.47	-0.57	0.82	0.93	0.87	0.96	0.91	0.85	0.92	0.94	0.38	0.86		-0.18	0.87	0.35	0.93	0.94	0.84	0.87
Long Term Debt Total	-0.17	-0.19	-0.12	-0.11	-0.13	-0.09	-0.11	-0.15	-0.22	-0.25	-0.05	-0.2	0.08	0.21	-0.18		-0.3	0.09	-0.22	-0.23	-0.17	-0.19
Intangible Assets	0.84	0.89	0.31	-0.62	0.69	0.83	0.7	0.88	0.9	0.91	0.87	0.85	0.59	0.83	0.87	-0.3		0.31	0.83	0.87	0.66	0.73
Short Long Term Debt	0.41	0.41	0.12	-0.51	0.37	0.49	0.37	0.45	0.44	0.36	0.49	0.37	0.38	0.44	0.35	0.09	0.31		0.37	0.38	0.31	0.32
Net Invested Capital	0.93	0.94	0.5	-0.54	0.84	0.91	0.88	0.94	0.86	0.8	0.88	0.92	0.3	0.79	0.93	-0.22	0.83	0.37		0.99	0.93	0.91
Net Working Capital	0.93	0.95	0.46	-0.56	0.83	0.91	0.86	0.95	0.88	0.85	0.89	0.91	0.34	0.82	0.94	-0.23	0.87	0.38	0.99		0.91	0.89
Capital Stock	0.91	0.89	0.53	-0.4	0.91	0.89	0.92	0.88	0.75	0.61	0.81	0.84	0.06	0.64	0.84	-0.17	0.66	0.31	0.93	0.91		0.88
Long Term Investments	0.9	0.88	0.54	-0.45	0.79	0.86	0.89	0.87	0.72	0.62	0.81	0.94	0.39	0.7	0.87	-0.19	0.73	0.32	0.91	0.89	0.88

Click cells to compare fundamentals

Year-To-Date typically refers to a period starting from the beginning of the current year and continuing up to the present day. Investors should becareful when comparing YTD ratios if not much of the year has occurred as research shows that YTD measures are more sensitive to early periods than late.

Competition

Predict Vericel Corp

Vericel Return On Tangible Assets

Return On Tangible Assets

(0.008671)

At this time, Vericel Corp's Return On Tangible Assets are quite stable compared to the past year.

As per the company's disclosures, Vericel Corp Ord has a Year To Date Return of 0.0%. This indicator is about the same for the Biotechnology average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).

Vericel Year To Date Return Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Vericel Corp's direct or indirect competition against its Year To Date Return to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Vericel Corp could also be used in its relative valuation, which is a method of valuing Vericel Corp by comparing valuation metrics of similar companies.

Vericel Corp is currently under evaluation in year to date return category among its peers.

Vericel Corp ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Vericel Corp's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Vericel Corp's managers, analysts, and investors.

Environmental

Governance

Social

Vericel Fundamentals

	Return On Equity	0.0154
	Return On Asset	-0.0022
	Profit Margin	0.02 %
	Operating Margin	(0.04) %
	Current Valuation	2.83 B
	Shares Outstanding	49.36 M
	Shares Owned By Insiders	0.91 %
	Shares Owned By Institutions	99.09 %
	Number Of Shares Shorted	3.71 M
	Price To Earning	357.33 X
	Price To Book	11.01 X
	Price To Sales	12.49 X
	Revenue	197.52 M
	Gross Profit	162.12 M
	EBITDA	2.86 M
	Net Income	(3.18 M)
	Cash And Equivalents	100.69 M
	Cash Per Share	2.13 X
	Total Debt	88.04 M
	Debt To Equity	0.28 %
	Current Ratio	6.20 X
	Book Value Per Share	5.23 X
	Cash Flow From Operations	35.31 M
	Short Ratio	11.02 X
	Earnings Per Share	0.08 X
	Target Price	64.14
	Number Of Employees	314
	Beta	1.67
	Market Capitalization	2.83 B
	Total Asset	353.66 M
	Retained Earnings	(403.18 M)
	Working Capital	159.88 M
	Current Asset	21.1 M
	Current Liabilities	15.36 M
	Net Asset	353.66 M

About Vericel Corp Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Vericel Corp Ord's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Vericel Corp using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Vericel Corp Ord based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Vericel Corp Ord is a strong investment it is important to analyze Vericel Corp's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Vericel Corp's future performance. For an informed investment choice regarding Vericel Stock, refer to the following important reports:

How To Invest In Vericel

Details

Is Vericel Stock a good investment?

Details

What is Vericel Corp's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Vericel Corp Piotroski F Score and Vericel Corp Altman Z Score analysis.

You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vericel Corp. If investors know Vericel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vericel Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

1.045

Earnings Share

0.08

Revenue Per Share

4.685

Quarterly Revenue Growth

0.27

Return On Assets

(0)

The market value of Vericel Corp Ord is measured differently than its book value, which is the value of Vericel that is recorded on the company's balance sheet. Investors also form their own opinion of Vericel Corp's value that differs from its market value or its book value, called intrinsic value, which is Vericel Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vericel Corp's market value can be influenced by many factors that don't directly affect Vericel Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Vericel Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vericel Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vericel Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Vericel Corp Ord Stock Year To Date Return

Vericel Corp Ord Company Year To Date Return Analysis

YTD Return

(Mean of Monthly Returns - 1)

X

100%

Vericel Year To Date Return Driver Correlations

Vericel Return On Tangible Assets

Return On Tangible Assets

(0.008671)

Vericel Year To Date Return Peer Comparison

Vericel Corp ESG Sustainability

Vericel Fundamentals

About Vericel Corp Fundamental Analysis

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY